Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: NORAMCO INC.

Referral inspection · Health discipline

On , OSHA opened a referral health inspection of NORAMCO INC. in 1550 OLYMPIC DR., ATHENS, GA 30601 (NAICS 325412). OSHA activity number 344405816.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Noramco INC. — free Get an email when a new federal OSHA severe-injury report for Noramco INC. is published. One employer, no account, unsubscribe in one click.
Establishment
NORAMCO INC.
Site address
1550 OLYMPIC DR.
City
ATHENS
State
GA
ZIP
30601
Mailing
1550 OLYMPIC DR., ATHENS, GA 30601
Inspection type
Referral (C)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
46
Ownership type
A

2 citations on file for this inspection.

1910.134 D01 III

Deleted Serious Gravity 5 1 instance 1 exposed
Issued
Nov 12, 2019
Abate by
Dec 9, 2019
Penalty
Initial $5,114 · Current $0 Reduced
29 CFR 1910.134(d)(1)(iii): The employer did not identify and evaluate the respiratory hazard(s) in the workplace; including a reasonable estimate of employee exposures to respiratory hazards and identification of the contaminant's chemical state and physical form:  Noramco Inc., Athens, GA - On or about October 16, 2019, an employee was recording data and entering the area where the milling of Buprenorphine Hydrochloride was being conducted, to check the testing process. An evaluation of the respiratory hazard for the employee recording data and checking the process was not performed resulting in an exposure to Buprenorphine Hydrochloride that resulted in a hospitalization of the employee.
Recent events (2)
  • — I (S) $0
  • — Z (S) $5114

1904.39 A02

Other-than-serious 1 instance 1 exposed
Issued
Nov 12, 2019
Penalty
Initial $6,394 · Current $6,394
29 CFR 1904.39(a)(2): The employer did not report within 24-hours a work-related incident resulting in in-patient hospitalization, amputation or the loss of an eye.  Noramco Inc., Athens, GA - On or about October 16, 2019, an employee was hospitalized after an exposure to Buprenorphine Hydrochloride. The hospitalization was not reported to OSHA until October 23, 2019.
Recent events (2)
  • — I (O) $6394
  • — Z (O) $6394

View Noramco INC.'s full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 344405816.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.